SCHEDULE INFORMATION

PRINTABLE SCHEDULE 

  • SCHEDULES

    • SCHEDULE OVERVIEW

      Subject to Change
      Posted  2/27/19  (please note that there will not be any Accreditation Surveyor Training at this year's Annual Meeting)

      START TIME

      END TIME

      EVENT

      LOCATION


      TUESDAY, June 25

      4:00 PM

      11:00 PM

      UHMS Board of Directors Meeting (Private Meeting)

       


      WEDNESDAY, June 26

      8:00 AM

      5:00 PM

      Pre-Course: How to Prepare for Accreditation

      Caribbean 1

      8:00 AM

      5:00 PM

      Pre-Course: Treatment of Decompression Illness in Recreational Diving

      Caribbean 2

      8:00 AM

      5:30 PM

      Pre-Course: Hyperbaric Oxygen Safety: Clinical and Technical Issues

      Caribbean 3

      1:00 PM

      3:00 PM

      CHT/CHRN Study Hall

      Heron

      3:30 PM

      5:30 PM

      CHT/CHRN Exam

      Heron

      4:45 PM

      7:45 PM

      HBO Therapy Committee Meeting

      Canary

      5:30 PM

      7:30 PM

      Associate's Council Meeting

      Pelican

      7:00 PM

      9:00 PM

      WELCOME RECEPTION

      Ocean Terrace & Rio Mar Foyer


      THURSDAY, June 27

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Rio Mar 5-Cord A

      7:00 AM

      8:00 AM

      Safety Committee Meeting

      Heron

      8:00 AM

      8:30 AM

      President's Address: Nick Bird, MD

      Rio Mar 6-10 & Cord B

      8:30 AM

      10:00 AM

      Plenary Session: Controversies in the Hyperbaric Management of Late
      Radiation Injuries

      Rio Mar 6-10 & Cord B

      8:30-9:00: 

      Late Radiation Tissue Injury Below the Clavicles: Considerations with IMRT and the Fibroatrophic Model: John Feldmeier, DO

      9:00-9:30: 

      Answering the criticism and challenges to HBO2 in the treatment of radiated patients: Robert Marx, DDS

      9:30-10:00: 

      Panel Discussion

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Rio Mar 5-Cord A

      10:00 AM

      12:00 PM

      Accreditation Council Meeting

      Heron

      10:00 AM

      11:00 AM

      ACEP UHM Section Meeting

      Canary

      10:30 AM

      11:30 AM

      Session A: HBO2 Theory & Mechanisms

      Rio Mar 6-10 & Cord B

      11:00 AM

      12:00 PM

      GME Committee Meeting

      Canary

      11:30 AM

      12:00 PM

      Poster Session A

      Rio Mar 1-4

      12:00 PM

      1:00 PM

      Stakeholders Summit Meeting (Private - invite only)

      Caribbean 1

      12:00 PM

      1:00 PM

      LUNCH

      Ocean Terrace/Rio Mar Foyer

      1:00 PM

      2:00 PM

      Kindwall Keynote: HBO2 in Chronic Radiation Injured Tissue and Osteoradionecrosis in Today’s Radiation Schemes: Needed Now Even More: Robert Marx, DDS

      Rio Mar 6-10 & Cord B

      2:00 PM

      3:00 PM

      Session B: Clinical HBO2

      Rio Mar 6-10 & Cord B

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Rio Mar 5-Cord A

      3:00 PM

      5:00 PM

      Editorial Board Meeting

      Heron

      3:30 PM

      4:00 PM

      Poster Session B

      Rio Mar 1-4

      4:00 PM

      5:00 PM

      Plenary Session: Physiology and Science in Hyperbaric Medicine

      Rio Mar 6-10 & Cord B

      4:00-4:30: 

      Stem cells and hyperberbaric oxygen therapy: Stephen Thom, MD 

      4:30-5:00: 

      Research that we need to do in the field of hyperbaric medicine and some thoughts on how to achieve this goal: John Feldmeier, DO

      5:00 PM

      6:00 PM

      Education Committee Meeting

      Pelican

      5:00 PM

      6:00 PM

      BNA Board Meeting

      Canary

      6:00 PM

      7:00 PM

      Exhibitor Wine & Cheese Reception

      Rio Mar 5-Cord A


      FRIDAY, June 28

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Rio Mar 5-Cord A

      7:00 AM

      8:00 AM

      Past President’s Breakfast

      Canary

      8:00 AM

      10:00 AM

      Plenary Session: DCI Theory & Mechanisms

      Rio Mar 6-10 & Cord B

      8:00-9:00: 

      CNS Oxygen toxicity: Where are we now? Jay Dean, PhD

      9:00-9:30: 

      Navy dive operations: Lessons learned about planning, DCS prevention and treatment:
      Pete Witucki, MD

      9:30-10:00: 

      Wearable diving technology: John Florian, PhD

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Rio Mar 5-Cord A

      10:30 AM

      11:30 AM

      Session C: Decompression Theory and Mechanisms

      Rio Mar 6-10 & Cord B

      10:00 AM

      11:00 AM

      ECCHO Working Group Meeting

      Heron

      10:00 AM

      11:00 AM

      Publication Committee Meeting

      Canary

      11:00 AM

      1:00 PM

      ACHM-UHMS Meeting

      Heron

      11:30 AM

      12:00 PM

      Poster Session C

      Rio Mar 1-4

      11:30 AM

      12:30 AM

      Registry Meeting (Buckey)

      Canary

      12:00 PM

      1:00 PM

      Stakeholder Summit Meeting (Private - invite only)

      Caribbean 1

      12:00 PM

      1:00 PM

      LUNCH

      Ocean Terrace & Rio Mar Foyer

      1:00 PM

      2:00 PM

      Lambertsen Keynote: Decompression sickness as an inflammatory disease: 
      Simon Mitchell, MBBS, PhD

      Rio Mar 6-10 & Cord B

      2:00 PM

      3:00 PM

      QUARC Committee Meeting

      Heron

      2:00 PM

      3:00 PM

      Session D: Diving Medicine

      Rio Mar 6-10 & Cord B

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Rio Mar 5-Cord A

      3:00 PM

      4:00 PM

      BNA General Meeting

      Pelican

      3:00 PM

      4:00 PM

      Research Committee Meeting

      Heron

      3:30 PM

      4:00 PM

      Poster Session D

      Rio Mar 1-4

      4:00 PM

      5:00 PM

      Plenary Session: Altitude Decompression Sickness

      Rio Mar 6-10 & Cord B

      4:00-4:30: 

      Combating flier’s “bends” during unpressurized flight and explosive decompression in World War II:
      Jay Dean. PhD

      4:30-5:00: 

      USAF hypobaric exposures experience: Marc Robins, DO

      5:00 PM

      6:00 PM

      UHMS Business Meeting - Open meeting

      Rio Mar 6-10 & Cord B

      5:30 PM

      7:30 PM

      Specialty Council Meeting (Toups) PRIVATE Meeting

      Pelican


      SATURDAY, June 29

      7:00 AM

      8:00 AM

      CONTINENTAL BREAKFAST / EXHIBITS

      Rio Mar 5-Cord A

      8:00 AM

      5:00 PM

      Non-Physician "Associates" Breakout Session (not approved for physician
      CME credits)

      Caribbean 2-3

      8:00 AM

      10:00 AM

      Plenary Session: The Regulatory And Reimbursement Challenges Facing Nations And How These Have Been Addressed

      Rio Mar 6-10 & Cord B

      8:00-8:25: 

      Canada: Ken LeDez, MD

      8:25-8:50: 

      United Kingdom: Pieter Bothma, MD

      8:50-9:15: 

      United States: Caroline Fife, MD

      9:15-9:40: 

      Australia: Michael Bennett, MD

      9:40-10:00:  Panel discussion

      10:00 AM

      10:30 AM

      BREAK / EXHIBITS

      Rio Mar 5-Cord A

      10:30 AM

      11:30 AM

      Session E: HBO2 Operations, Chambers, and Equipment

      Rio Mar 6-10 & Cord B

      11:30 AM

      12:00 PM

      Poster Session E

      Rio Mar 1-4

      10:00 AM

      11:00 PM

      Chapter President's Committee Meeting

      Pelican

      10:00 AM

      12:00 PM

      Diving Committee Meeting

      Canary

      11:00 AM

      12:00 PM

      Membership Committee Meeting

      Pelican

      12:00 PM

      1:00 PM

      LUNCH

      Ocean Terrace & Rio Mar Foyer

      12:00 PM

      1:00 PM

      Associates Luncheon (limited to 50)

      Caribbean 1

      1:00 PM

      2:00 PM

      Plenary Session:

      Rio Mar 6-10 & Cord B

      1:00-1:30: 

      HBO2 and Inflammatory Bowel Disease Update: Jay Buckey, MD

      1:30-2:00: 

      Thai dive rescue: Richard Walker, MD

      2:00 PM

      3:00 PM

      Session F: Top Case Reports

      Rio Mar 6-10 & Cord B

      3:00 PM

      3:30 PM

      BREAK / EXHIBITS

      Rio Mar 5-Cord A

      3:30 PM

      4:00 PM

      Poster Session F

      Rio Mar 1-4

      4:00 PM

      5:00 PM

      Plenary Session: Topics in Undersea and Hyperbaric Medicine

      Rio Mar 6-10 & Cord B

      4:00-4:30: 

      Top articles in HBO2: Fellow (TDB)

      4:30-5:00: 

      Top articles in Undersea Medicine: Fellow (TDB)

      7:00 PM

      10:00 PM

      Awards Banquet (separate fee)

      Rio Mar 5-Cord A

      10:00 PM

      12:00 AM

      After Party (separate fee)

      Ocean Terrace & Caribbean 2-3

       

       

       

       

       

       

      Read more

    • GENERAL SESSION SCHEDULE

      THURSDAY, JUNE 27 - SATURDAY, JUNE 29
      PDF copy
      Subject to change
      Posted 5/21/18


       

       

       

      Read more

    • PRE-COURSE SCHEDULES

      PRE-COURSES: WEDNESDAY, JUNE 26

      How to Prepare for Accreditation       Hyperbaric Oxygen Safety: Clinical and Technical Issues       
      Treatment of Decompression Illness in Recreational Diving

      subject to change: posted: 2/19/19 


      How to Prepare for Accreditation

      TIME

       LECTURE FACULTY

      0800-0815

      Welcome/Introductions                                                      

      Derall Garrett

      0815-1015

      Why Accredit Clinical Hyperbaric Facilities?       

      Derall Garrett

      1015-1045

      Break

       

      1045-1145

      Hyperbaric Facility Accreditation Program Design I  & II

      Derall Garrett

      1145-1245

      Lunch

       

      1245-1330

      Physician point of view                                                   

      Henry Schwartz

      1330-1415

      Nurse point of view

      Debra Gonzalez

      1415-1500

      Technologist point of view                                                     

      Tom Workman

      1500-1515

      Break

       

      1515-1545

      Organizational Planning                                            

      Derall Garrett

      1545-1600

      Discussion/Questions

       

      1600

      Adjourn

       

       Hyperbaric Oxygen Safety: Clinical and Technical Issues

      TIME   LECTURE FACULTY
      0800 - 0815                                Introductions: / Welcome  Marc Robins, DO
      Andrew Melnyczenko, CHT

      0815 - 0915 Safety considerations in hyperbaric medicine: Lessons from aviation, space, and other industries Gary Toups, MD

      0915 - 1015 The role of the medical director in the safety program Marc Robins, DO

      1015 - 1030

      Break

       
      1030 - 1050 How to implement the nursing guidelines of care to improve safety in your HBO program Annette Gwilliam, RN, BSN, CWON, CWS, ACHRN

      1050 - 1110 Human factors that impact safety in hyperbaric Richard “Gus” Gustavson, MPH, RN, CHRNC-A, CWCN, CHT-A, CRT

      1110 - 1130 Optimizing the pediatric hyperbaric oxygen therapy plan: Tandem therapy Nicholas Marosek, CHRN, ACCRN 

      1130 - 1200 Panel Q&A from the morning session  Moderator: 
      Andrew Melnyczenko, CHT

      1200 - 1300 

      Lunch   
      1300 - 1345 Safety-related trends revealed from the UHMS Facility Accreditation Program Tom Workman, CHT

      1345 - 1430 Assessing the safety of diver recompression chamber facilities. A retrospective review of the most common safety concerns encountered at a range of recompression facilities over a period of 13 years Francois Burman



      1430 - 1445

      Break  
      1445 - 1530 Safety versus Compliance Kip Posey, CHT

      1530 - 1600 International survey of equipment used in hyperbaric facilities Marc Pullis, EMT, CHT

      1600 - 1645 Biomedical devices in the hyperbaric environment Ian Millar, MD

      1645 - 1715 Panel Q & A from the afternoon session  Moderator: Ian Millar, MD

      1715 - 1730 Closing/ Course evaluations / Questions  Marc Robins, DO
      Andrew Melnyczenko, CHT


      Treatment of Decompression Illness in Recreational Diving

      Time

      Lecture

      Faculty

      08:00-08:30

      Current UHMS guidelines

      Nick Bird

      08:30-09:00

      Polling, hidden results: DCI treatment principles (see the list of Q&A in Appendix)

      Petar Denoble

      09:00-09:30

      Current practice in France

      Sébastien de Maistre

      09:30-10:00

      Current practice in China

      Wei-gang Xu

      10:00-10:30

      Coffee Break

       

      10:30-11:00

      Australian experience

      David Wilkinson

      11:00-11:30

      Could normobaric oxygen be accepted as a definitive treatment?

      Richard Moon

      11:30-12:00

      Use of short tables in treatment of DCI

      Brenna Derksen

      12:00-12:30

      Treatment of severe DCS cases

      Ian Grover

      12:30-13:30

      Lunch break

       

      13:30-13:45

      Use of deep tables in US Navy

      David Southerland

      13:45-14:30

      Is it ever too late to treat?

      Jake Freiberger

      14:30-15:00

      Flying after treatment

      Jim Chimiak

      15:00-15:30

      Return to diving after DCI

      Jake Freiberger

      15:30-15:45

      coffee break

       

      15:45-16:45

      Polling, public results: DCI treatment principles. Discussion of each question. Comparison of pre- and post- answers

      Petar Denoble

      16:45-17:00

      Concluding remarks

      Petar Denoble

      Read more

    • NON-PHYSICIAN TRACK SCHEDULE

      SATURDAY, JUNE 29
       (subject to change)
      (not approved for physician CME credits)

      TIME LECTURE

      FACULTY

      8:00-8:10

      Welcome & Introductions

      Kaye Moseley, RRT / Bradley Walker, RN

      8:10-8:20 

      UHMS Associates Update

      Jolene Comier, RN

      8:20-8:40

      BNA Update

       

      8:40 - 9:00

         

      9:00-9:30

         

      9:30-9:45

         

      9:45-10:00

         

      10:00-10:30

      Break/Exhibits

       

      10:30-10:45 

         

      10:45-11:00 

      Q & A

       

      11:00-11:15

      Achievement Recognition Scholarship Abstract:

       

      11:15-11:30 

         

      11:30-11:45

         

      11:45-12:00 

         

      1200-1:00

      LUNCH

       

      1:00-2:00

       

       

      2:00-2:45

         

      2:45-3:00

         

      3:00-3:30

      Break/Exhibits

       

      3:30-3:45

         

      3:35-4:00

         

      4:00-4:20

         

      4:20-5:00

         

       

       

       

      Read more

    • ABSTRACT SCHEDULE


       


       

       

      Read more

    Read more

  • Keynote Lectures

    • ERIC P. KINDWALL, MD MEMORIAL LECTURE

      THURSDAY, JUNE 27: 1:00 pm - 2:00 pm

      GUEST SPEAKER: ROBERT MARX, DDS

      LECTURE TITLE: HBO2 in Chronic Radiation-Injured Tissue and Osteoradionecrosis in Today’s Radiation Schemes: Needed Now Even More

       

      ABOUT THE LECTURE: 

      MarxToday’s radiotherapy schemes, particularly intensity modulated radiation therapy (IMRT), are often used as primary therapy for head and neck cancers. Used together with chemotherapy it has produced a higher incidence of radiation-induced complications. The wider fields, higher doses, and radio sensitizing chemotherapy has caused a more severe and wider spread of osteoradionecrosis (ORN), now even including the previously rare ORN of the maxilla as well as permanent mucositis, skin necrosis, dysphagia, and even some facial nerve palsies.

      The role of HBO2 remains the same adjunct to surgical debridements but requires the full 30/10 HBO2 protocol to be conducted at the proven parameters at 2.4 ATA , 90 minutes on 100% O2 with air breaks and without interruption in the treatment sequence.

      After resection or debridement of the necrotic bone, the resultant bony defect can be reconstructed today using tissue engineering in most cases as a single modality or together with a smaller amount of autogenous bone, thereby reducing the morbidity of treatment. Additionally, these bone grafting techniques produce a quality of normal viable bone suitable for dental implants to replace teeth lost in the ORN disease process, aiding the patient’s return to a more normal quality of life.

      ABOUT DR. MARX:  

      Robert E. Marx, DDS, is Professor of Surgery and Chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine as well as Chief of Surgery at Jackson South Community Hospital in Miami. He is well known as an educator, researcher, and innovative surgeon. Dr. Marx has pioneered new concepts and treatments for pathologies of the oral and maxillofacial area as well as new techniques in reconstructive surgery, including stem cell therapies. 

      His many prestigious awards, including the Harry S. Archer Award, the William J. Giles Award, the Paul Bert Award, the Donald B. Osbon Award, and the Daniel Laskin Award, attest to his accomplishments and commitment to the field of oral and maxillofacial surgery. 

      His textbook “Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment” has won the American Medical Writers Associations Prestigious Book of the Year Award. His other textbooks, “Platelet Rich Plasma: Dental and Craniofacial Applications,” “Tissue Engineering,” “Oral and Intravenous Bisphosphonates Induced Osteonecrosis” and an “Atlas of Bone Harvesting” have been best sellers. He is also a writer of fiction medical mystery novels. His first publication “Deadly Prescription” is currently an Amazon best seller.



      ERIC P. KINDWALL, MD MEMORIAL LECTURE
      About Dr. Kindwall:

      KINDWALL PICDr. Kindwall is known by so many as the "Father of Hyperbaric Medicine.” Whether you knew him personally or simply by reputation, we have all benefited from his efforts, passion, wisdom, knowledge, energy and vision. Dr. Kindwall has played a great role in growing and shaping the specialty of Undersea and Hyperbaric Medicine. He was likewise instrumental in molding the UHMS into what it is today.  Dr. Kindwall began diving in 1950. He cultivated his interest in the field and during the Vietnam War served as the Assistant Director of the U.S. Navy School of Submarine Medicine. He also was the Senior Officer responsible for the Diving Medicine Program. In 1969, after leaving the Navy, Dr. Kindwall became Chief of the Department of Hyperbaric Medicine at St. Luke’s Medical Center, Milwaukee, Wis.  Shortly after the Undersea Medical Society was created in the mid-1960s, Dr. Kindwall identified the need for standardized education in the field. He created the UMS Education and Standards Committee to help elevate course content and ensure instructor competence. This committee later became our Education Committee. When the AMA initiated its Continuing Medical Education program, Dr. Kindwall persuaded the organization to recognize the UMS as a grantor of CME credits.  In 1972, Dr. Kindwall felt that the Society’s members would benefit from improved communication. He created our first newsletter and was named editor. Dr. Kindwall chose the name Pressure because clinical hyperbaric medicine was rapidly developing. Even though the UHMS had not yet incorporated "Hyperbaric” into the Society’s name, he wanted a title for the newsletter that would encompass all who worked with increased atmospheric pressure. He stated: "The Society’s goal then, as it is now, is to serve all who deal with the effects of increased barometric pressure.”  That same year, Dr. Kindwall recognized the need to have a relationship with Medicare to help provide insight on reputable clinical management. The UMS followed this lead, and a Medicare Panel was created. The recommendations were presented to the U.S. Public Health Service. The challenge was that no reliable hyperbaric medicine clinical guidelines were available that addressed appropriate applications of Hyperbaric Medicine. To remedy this deficit, the UMS Executive Committee created an Ad Hoc Committee on hyperbaric oxygen therapy. Dr. Kindwall was named Chair. The committee created the first Hyperbaric Oxygen Therapy Committee Report. Again, this text was published 10 years before the UHMS incorporated "Hyperbaric” into its name. The report was sent to HCFA and the Blues and became their source document for reimbursement. Dr. Kindwall updated the text two more times and thus was the Editor and Chair of the Committee and text for three of its 12 editions.  Dr. Kindwall later worked to expand the available information on the specialty by creating one of the first complete texts on the field. He created Hyperbaric Medicine Practice in 1994 and later updated and revised his text two more times.  The Society’s first journal, Hyperbaric Oxygen Review, has also has been influenced by Dr. Kindwall. His love for research and education was clear: He became the initial editor, creating a journal that at first consisted of review articles and one original contribution. Over the years,it has grown to one full of original research.  Dr. Kindwall’s presence is felt in so many of the UHMS’ activities and initiatives. Much of what we all take for granted – what is just "there” and "available” – has his touch and influence. Some of us have been blessed to have had a closer impact by Dr. Kindwall’s life, but I think that I can easily say that each of us has been influenced in some way.

       



      ::/introtext::
      ::fulltext::::/fulltext::

    • CHRISTIAN J. LAMBERTSEN MEMORIAL LECTURE

      FRIDAY, JUNE 28: 1:00 pm - 2:00 pm

      GUEST SPEAKER: SIMON MITCHELL, MBBS, PHD

      LECTURE TITLE: Decompression Sickness As An Inflammatory Disease


      ABOUT THE LECTURE:

      Mitchell

      It has long been considered that decompression sickness (DCS) is a disorder in which bubbles formed from dissolved gas in blood and / or tissue during or after ascent from a compressed-gas dive are the primary vectors of injury. The existence of such bubbles and their potential to cause or contribute to at least some of the manifestations of DCS have been proven. However, uncertainties remain. While the risk of developing symptoms of DCS correlates with numbers of venous bubbles detected using Doppler or echocardiography after diving, the correlation is not as strong as one might expect if bubbles were the only contributor to tissue injury. There are various potential explanations for this, including the possibility that a variably expressed secondary process of inflammation may contribute to the clinical picture. We have known for some time that intravascular bubbles, or the damage they may cause to vascular endothelium, appear to activate formed elements of blood and plasma proteins. Thus, bubbles may directly or indirectly activate platelets, leukocytes, the complement and kinin systems, and coagulation. There is some evidence that these activations contribute to development of some manifestations of DCS. More recently there has been intense interest in the role of proinflammatory intravascular microparticles (circulating fragments of formed elements of blood) in the pathophysiology of DCS. Microparticles may form during diving and increase after any dive, but perhaps moreso in divers exhibiting DCS symptoms. The relationship between bubble and microparticle formation is uncertain. There is some evidence that microparticles may produce harmful effects relevant to the pathophysiology of DCS, and there has been controversial speculation that microparticles may be a primary cause of some DCS manifestations. This presentation will review the pathophysiology of DCS with a particular focus on the potential role of inflammatory processes. Related unanswered questions and uncertainties will be identified.

       
      ABOUT  DR. MITCHELL: 
      Professor Simon Mitchell, MB ChB, PhD, DipAdvDHM, DipOccMed, FUHM, FANZCA. 
      Professor of Anesthesiology, School of Medicine, University of Auckland

      Dr. Mitchell is a physician and scientist with specialist training in diving medicine and anesthesiology. He is widely published, with more than 150 papers or book chapters. He co-authored the 5th edition of “Diving and Subaquatic Medicine” and has two chapters on decompression illness in the most recent edition of Bennett and Elliott. He has twice been Vice President of the Undersea and Hyperbaric Medical Society and in 2010 received the society’s Behnke Award for contributions to the science of diving and hyperbaric medicine. In the past Simon was a naval diving medical officer and medical director of the Wesley Centre for Hyperbaric Medicine in Brisbane. He now works as a consultant anesthesiologist at Auckland City Hospital, and Professor in Anesthesiology at the University of Auckland. He provides on-call cover for diving and hyperbaric emergencies at the North Shore Hospital Hyperbaric Unit in Auckland. Simon is Editor-In-Chief of Diving and Hyperbaric Medicine Journal.

      Simon’s diving career has included more than 6,000 dives spanning sport, scientific, commercial, and military diving. He has been a lead member of teams that were the first to dive and identify three deep wrecks of high historical significance in Australia and New Zealand. At the time of one of these dives (2002) the 600-foot depth represented the deepest wreck dive ever undertaken. He was elected to Fellowship of the Explorers Club of New York in 2006, and was the DAN Rolex Diver of the Year in 2015.


      CHRISTIAN J. LAMBERTSEN, MD, DSc (Hon) MEMORIAL LECTURE
      About Dr. Lambertsen:

      LAMBERTSEN PIC

      Dr. Christian J. Lambertsen received a B.S. Degree from Rutgers University in 1938 and a M.D. Degree from the University of Pennsylvania in 1943. During his medical school period, he invented and first used forms of the initial U.S. self-contained closed-circuit oxygen rebreathing apparatus, for neutral buoyancy underwater swimming and diving. As a student, he aided the early Office of Strategic Services (O.S.S.) in establishing the first cadres of U.S. military operational combat swimmers. Dr. Lambertsen became a U.S. Army medical officer on graduation from medical school in early 1943, and immediately joined the O.S.S. Maritime Unit on active duty through its period of function in World War II. He joined the University of Pennsylvania Medical Faculty in 1946, and became Professor of Pharmacology in 1952. While a faculty member he combined diving research and further underwater rebreathing equipment developments for the Army and Navy. In 1967 he served as Founding President of the Undersea Medical Society (now Undersea and Hyperbaric Medical Society.) Dr. Lambertsen is recognized by the Naval Special Warfare community as "The Father of U.S. Combat Swimming.” His hand has touched every aspect of military and commercial diving. Dr. Lambertsen’s active contributions to diving began during WWII and became even more progressive in the post-war period through the evolutions of the U.S. Navy Deep Submergence and Naval Special Warfare developmental programs. 

      ::/introtext::
      ::fulltext::::/fulltext::

    Read more

  • Plenary Sessions

    • Thursday, June 27

       


      PRESIDENT'S ADDRESS

      8:00-8:30:


      Nicholas Bird, MD, FUHM

      BirdNicholas WEB NEW
      Overview
      : Provide an overview of activities, plans, and outcomes from initiatives carried out by UHMS home office, officers and committees. 

      Objectives:

      • Name two of the position statements published in the last year.
      • Describe what the UHMS has done to improve its editorial review process

      About Dr. Bird:  Dr. Nicholas Bird is a regional medical director for Duke Urgent Care and am board-certified in both family medicine and undersea and hyperbaric medicine. He split my time between clinical practice and administrative responsibilities, and he have a passion for improving health care delivery to optimize patient access, education and outcomes. Prior to joining the Duke medical staff, he was the chief medical officer and CEO of Divers Alert Network and an internationally recognized expert on diving injuries, accidents and medical treatment. Outside of work, he enjoy traveling, and diving the warm waters of the world. He has been a PADI SCUBA instructor for more than 25 years. He also enjoy reading Clive Cussler novels, cooking, and golfing, when time permits. He live in Durham with his wife, Kim. They have three children, a grandson, and a crazy Jack Russell terrier.


      Controversies in the Hyperbaric Management of Late Radiation Injuries

       
      8:30-9:00:


      Late Radiation Tissue Injury Below the Clavicles: Considerations with IMRT and the Fibroatrophic Model
      John Feldmeier, DO

      Feldmeier Pic OfficialIn this session, Dr. Feldmeier will join with Dr. Robert Marx to address several recent articles calling into question the role of hyperbaric oxygen in treating LRTI’s (Late Radiation Tissue Injuries). While Dr. Marx will concentrate on the application of Hyperbaric Oxygen to osteoradionecrosis (ORN) of the mandible and maxilla and soft tissue injuries of the head and neck, Dr. Feldmeier will concentrate on injuries to organs and tissues below the clavicle. Special emphasis will be given to radiation cystitis and proctitis. The technique of modern radiation therapy targeting including IMRT (Intensity Modulated Radiation) will be briefly discussed. A recently proclaimed and popular model of delayed radiation injury is called the Fibroatrophic Model. It de-emphasizes vascular damage as the major contributor to LRTI. This model will be discussed from 2 perspectives: 1. Its validity and 2. Even if accepted in part or in toto, how a strong case for the use of hyperbaric oxygen can be made. At the conclusion of both Dr. Marx’s and Dr. Feldmeier’s plenary sessions, a panel discussion will occur.

      About Dr. Feldmeier: Dr. Feldmeier received his D.O. degree from The Philadelphia College of Osteopathic Medicine in 1979 with USAF sponsorship and completed residency training in Radiation Oncology at the University of Texas Health Science Center at San Antonio, Texas in 1985. He received a fellowship certificate from the USAF Hyperbaric Medicine Fellowship Training Program at Brooks Air Force Base in San Antonio, Texas and was a staff physician there from 1980 to 1982. Dr. Feldmeier was simultaneously the Chief of Radiation Oncology and Chairman of the Hyperbaric Medicine Department at Wright-Patterson Air Force Base Medical Center in Dayton, Ohio before separating from the USAF in 1985. Dr. Feldmeier has served as the Chief of Radiation Oncology at the University of Texas Health Science Center in San Antonio, Grace Hospital in Detroit, MI and the Chairman of Radiation Oncology at the University of Toledo Medical Center from which he retired in 2013 with the award of Professor Emeritus. Dr. Feldmeier has authored numerous publications in both radiation oncology and hyperbaric medicine. He has been the editor of the Undersea & Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report. He served as review editor of Undersea and Hyperbaric Medicine. He is a Fellow of Undersea and Hyperbaric Medicine and Past- President of the UHMS. He currently co-chairs the UHMS Research Committee. He is a Fellow of the American College of Radiation Oncology.   He is a medical consultant to International ATMO. He is the only physician in the U.S. board certified in both Radiation Oncology and Undersea and Hyperbaric Medicine. 

       9:00-9:30:

      Answering the criticism and challenges to HBO2 in the treatment of radiated patients
      Robert Marx, DDS

      Marx 

       

       

      About Dr. Marx:  Robert E. Marx, DDS, is Professor of Surgery and Chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine as well as Chief of Surgery at Jackson South Community Hospital in Miami. He is well known as an educator, researcher, and innovative surgeon. Dr. Marx has pioneered new concepts and treatments for pathologies of the oral and maxillofacial area as well as new techniques in reconstructive surgery, including stem cell therapies. 
           His many prestigious awards, including the Harry S. Archer Award, the William J. Giles Award, the Paul Bert Award, the Donald B. Osbon Award, and the Daniel Laskin Award, attest to his accomplishments and commitment to the field of oral and maxillofacial surgery. 
            His textbook “Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment” has won the American Medical Writers Associations Prestigious Book of the Year Award. His other textbooks, “Platelet Rich Plasma: Dental and Craniofacial Applications,” “Tissue Engineering,” “Oral and Intravenous Bisphosphonates Induced Osteonecrosis” and an “Atlas of Bone Harvesting” have been best sellers. He is also a writer of fiction medical mystery novels. His first publication “Deadly Prescription” is currently an Amazon best seller.

      9:30-10:00: Panel discussion


      Physiology and Science in Hyperbaric Medicine


      4:00-4:
      30:


      Stem cells and hyperbaric oxygen therapy
      Stephen Thom, MD

      Thom picThe first scientific papers reporting effects of hyperbaric oxygen therapy (HBOT) on stem cell biology were published just 12 years ago and now they number over 100. This presentation will summarize the latest data on stem cell physiological responses to HBOT. Oxygen acts as a critical regulator of stem cells, and HBOT has a variety of effects on stem cell mobilization dynamics, metabolism, engraftment, and can influence paracrine roles with tissue repair. Some effects appear with the initial HBOT exposure while others develop when repeated hyperoxia-normoxia cycling occurs. Mechanisms and data on clinical utilization will be presented, as well as current questions and future directions.

      About Dr. Thom: Dr. Thom received his MD and PhD (microbial physiology) degrees from the University of Rochester in 1981. He served as professor of emergency medicine and chief of hyperbaric medicine at the University of Pennsylvania for 27 years and in July 2013 took a position at University of Maryland. He is a practicing emergency medicine physician and also carries out research in several areas. He is lead/senior author on over 130 peer reviewed papers and 40 reviews or textbook chapters on oxygen and other gas toxicities. Research interests include the role of stem cells in diabetic wound healing and cell responses to hyperoxia, pathophysiology of decompression sickness, carbon dioxide and carbon monoxide (CO). His lab group was the first to describe vasculogenic stem cell mobilization by hyperbaric oxygen therapy and he currently directs projects to assess the role of stem cells in diabetic skin wound healing. He was president of the UHMS from 1996-1998, and chair of the hyperbaric oxygen therapy committee from 1991-1993.  Dr. Thom has been the recipient of the Albert R. Behnke award of the UHMS in 1996 and 2008, the Paul Bert award from UHMS in 2007, the Edgar End award of the Gulf Coast Chapter of the UHMS in 1988, and the C. Longoni award from the Italian Undersea and Hyperbaric Medical Society in 1998.

      4:30-5:00:

      Research that We Need to do in the Field of Hyperbaric Medicine and Some Thoughts on How to Achieve this Goal
      John Feldmeier, DO (Co-chairman of the UHMS Research Committee)

      Feldmeier Pic OfficialIt is no surprise to our membership that as a discipline, hyperbaric medicine has not achieved a consistently successful track record in accomplishing research to further advance the application of our treatment modality or even for that matter to firmly solidify those indications that we accept as “Approved.” CMS and commercial insurers are actively involved in removing re-imbursements for pharmaceuticals, devices and procedures unless their proponents can make a solid argument for their benefit based on good and adequate science. It is likely that payments for our clinical efforts are going to be put under even greater scrutiny unless new and corroborating science is done and published with a quality that is readily acceptable to payors and potential referring physicians alike. As a small field, we do not have the luxury of large sums of money available to support the conduct large research protocols involving randomized controlled trials. We can, however, learn from the major cooperative oncologic trial groups and employ registries to achieve the necessary quality of science. A number of promising new applications deserve scrutiny and some of our long-standing indications need better support. This talk will be designed to identify several areas where research must be done for the good of our patients and our discipline and will consider some methods by which these studies can be accomplished.

      About Dr. Feldmeier: Dr. Feldmeier received his D.O. degree from The Philadelphia College of Osteopathic Medicine in 1979 with USAF sponsorship and completed residency training in Radiation Oncology at the University of Texas Health Science Center at San Antonio, Texas in 1985. He received a fellowship certificate from the USAF Hyperbaric Medicine Fellowship Training Program at Brooks Air Force Base in San Antonio, Texas and was a staff physician there from 1980 to 1982. Dr. Feldmeier was simultaneously the Chief of Radiation Oncology and Chairman of the Hyperbaric Medicine Department at Wright-Patterson Air Force Base Medical Center in Dayton, Ohio before separating from the USAF in 1985. Dr. Feldmeier has served as the Chief of Radiation Oncology at the University of Texas Health Science Center in San Antonio, Grace Hospital in Detroit, MI and the Chairman of Radiation Oncology at the University of Toledo Medical Center from which he retired in 2013 with the award of Professor Emeritus. Dr. Feldmeier has authored numerous publications in both radiation oncology and hyperbaric medicine. He has been the editor of the Undersea & Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report. He served as review editor of Undersea and Hyperbaric Medicine. He is a Fellow of Undersea and Hyperbaric Medicine and Past- President of the UHMS. He currently co-chairs the UHMS Research Committee. He is a Fellow of the American College of Radiation Oncology.   He is a medical consultant to International ATMO. He is the only physician in the U.S. board certified in both Radiation Oncology and Undersea and Hyperbaric Medicine.

    • Friday, June 28


      DCI Theory & Mechanisms

       8:00-9:00:

      CNS Oxygen toxicity: Where are we now?
      Jay Dean, PhD

      Dean2Hyperbaric oxygen (HBO2) is breathed during hyperbaric oxygen therapy and during certain undersea pursuits in diving and submarine operations. What limits exposure to HBO2 in these situations is acute onset of central nervous system oxygen toxicity (CNS-OT) following a latent period of safe oxygen breathing. CNS-OT presents as various non-convulsive signs and symptoms (S/Sx), many of which appear to be of brainstem origin that involve cranial nerve nuclei, autonomic centers and cardiorespiratory centers, which ultimately spread to higher cortical centers and terminate in recurring bouts of generalized tonic-clonic seizures. The initial latent period makes breathing HBO2 practical in hyperbaric and undersea medicine; however, the safe latent period is highly variable between individuals and within the same individual on different days, making it difficult to predict onset of toxic indications. Consequently, currently accepted guidelines for safe HBO2 exposure in undersea medicine and HBO2 therapy are highly conservative. During this lecture, I will review the results of research on CNS-OT, focusing on work done during the past two decades on behalf of the Office of Naval Research (ONR) Undersea Medicine Program (one of four National Naval Responsibility Initiatives) and the Naval Sea Systems Command (NAVSEA). Topics that will be covered include the following: the pathophysiology of the S/Sx that define CNS-OT; conditions that increase the risk for developing acute toxic indications during exposure to HBO2; innovative animal (in vitro and in vivo) and human research methods adapted for use during HBO2 that have provided insight on the neural mechanisms underlying CNS-OT; brain regions that are thought to be involved in seizure genesis and propagation; and current strategies under investigation for predicting an impending seizure (“physiomarkers”) and delaying onset of CNS-OT (antiepileptic drug therapy, antiadrenergic drug therapy, ketone metabolic therapy and hyperbaric oxidative preconditioning) with the goal of longer and safer dives without impaired performance (author’s research funded by ONR Undersea Medicine).

      About Dr. Dean: Dr. Jay B. Dean is a professor of Molecular Pharmacology & Physiology at the University of South Florida in Tampa. He currently teaches respiratory physiology in the Morsani College of Medicine and directs the USF Hyperbaric Biomedical Research Laboratory, which is funded by the ONR’s Undersea Medicine Program to study the pathophysiology of CNS oxygen toxicity. Dean is a devoted historian of aeromedical research during World War II, a topic he has researched extensively since his days as a PhD graduate student at Ohio State. Dean hails from Mason, Michigan, and received his training from Central Michigan University (BS 1979, Biology), Michigan Technological University (MS 1981, Biol. Sci.), The Ohio State University (PhD 1986, Physiology), and did his postdoctoral training in neurophysiology and respiratory control at the University of North Carolina-Chapel Hill (1986-91). Jay lives in Land O’Lakes, Florida with his wife, Janet, who teaches biology and oceanography at Pasco Hernando State College.

      9:00-9:30: Navy dive operations: Lessons learned about planning, DCS prevention and treatment
      Pete Witucki, MD


      9:30-10:00:

      Wearable diving technology
      John Florian, PhD

       


      Altitude Decompression Sickness

      4:00-4:30: Combating flier’s “bends” during unpressurized flight and explosive decompression in World War II
      Jay Dean. PhD

      Dean2The air war of 1939-45 was a “physiological war” because the Allies sought extreme altitudes in unpressurized warplanes to gain the tactical advantage in aerial combat. How high? In 1940, the Allies predicted the air war; thus WWII would be won by the side that waged combat operations at 40,000 feet. Altitude flying and fighting at 40,000 feet became the goal that would inspire America’s aeromedical research program for the war’s duration.

      Accordingly, reducing the risk of decompression sickness (DCS) at altitudes above 30,000-35,000 feet in unpressurized aircraft became a major research challenge for the physiologists of the U.S. Army Air Forces (USAAF) and U.S. Navy (USN). In April 1944, America deployed its first pressurized bomber (Boeing B-29 Superfortress) in the Pacific theater of operations to alleviate the physiological problems caused by hypobaric pressure, anoxia and cold. Pressurized flight, however, created a new problem: Namely, it was unknown how aircrews would respond to explosive decompression at high altitude following structural failure of their ship’s pressure cabin (6.5 psig). Would the incidence of DCS increase compared to slower rates of decompression in unpressurized airplanes?

      In this lecture, Dr. Dean will revisit the research and mitigation strategies for dealing with “flier’s bends” or “aeroembolism” during unpressurized flight and following explosive decompression during pressurized flight. Topics covered include the following:

      • discovery of flier’s bends during altitude chamber “flights” by Dr. Harry G. Armstrong at Wright Field, Dayton, Ohio (1934-1938);
      • development of oxygen prebreathing (OPB) to “denitrogenate” prior to altitude flying above 30,000 feet in altitude chambers and aircraft (1938-1945: Wright Field Aero Medical Lab and Mayo Aero Medical Unit with Boeing and Lockheed Aircraft Companies);
      • Dr. Fred A. Hitchcock’s pioneering research on the physiology of explosive decompression (1941-45: The Ohio State University Laboratory of Aviation Physiology); and more.

      Ultimately, the air war of 1939-1945 would be mostly fought and won below 40,000 feet; however, the equipment and procedures developed during the war years were immediately available for higher altitude flight during the post-war jet era.

      About Dr. Dean: Dr. Jay B. Dean is a professor of Molecular Pharmacology & Physiology at the University of South Florida in Tampa. He currently teaches respiratory physiology in the Morsani College of Medicine and directs the USF Hyperbaric Biomedical Research Laboratory, which is funded by the ONR’s Undersea Medicine Program to study the pathophysiology of CNS oxygen toxicity. Dean is a devoted historian of aeromedical research during World War II, a topic he has researched extensively since his days as a PhD graduate student at Ohio State. Dean hails from Mason, Michigan, and received his training from Central Michigan University (BS 1979, Biology), Michigan Technological University (MS 1981, Biol. Sci.), The Ohio State University (PhD 1986, Physiology), and did his postdoctoral training in neurophysiology and respiratory control at the University of North Carolina-Chapel Hill (1986-91). Jay lives in Land O’Lakes, Florida with his wife, Janet, who teaches biology and oceanography at Pasco Hernando State College.

      4:30-5:00: USAF hypobaric exposures experience
      Marc Robins, DO

      RobinsDr. Robins will speak on DCS altitude current problems faced and U2 case reports recently collected.

      About Dr. Robins: Dr. Robins started his career in medicine working for the Ski Patrol in Southern Oregon at age 19 which soon led to employment as a nurses aide then as a Registered Nurse. Prior to medical school he worked as an RN in the Emergency Department at a level 1 Trauma Center, graduating with his Doctorate in Osteopathy in 1988. Receiving a Health Professions Scholarship to pay for Medical School he did his first Residency in Family Practice at the David Grant USAF Regional Medical Center at Travis AFB, California, and then a second Residency in Aerospace Medicine with Fellowship in Occupational Medicine and a Masters in Public Health from Harvard University School of Public Health. He was awarded the Malcom Grow Air Force Outstanding Flight Surgeon of the Year Award in 1995, and completed a 20-year career as an Air Force Flight Surgeon. His assignments included European Aeromedical Evacuation Squadron, and command positions for Fighter Base Aeromedical Squadrons and the High Altitude U2 program in Beale, California, commanding medical services in six major deployments and one Humanitarian Mission. Dr. Robins culminated his career as the US Aerospace Medicine Consultant to the Australian Defence Force Medical Chief (US Surgeon General equivalent), retiring as a Colonel. He attended the NOAA Dive Medical course in 2010 and maintains an avid interest in recreational scuba diving, certifying in 2003. He is a pilot, enjoys skiing, mountain biking, motorcycle riding and rock climbing.

       

    • Saturday, June 29


      The Regulatory And Reimbursement Challenges Facing Nations And How These Have Been Addressed

      8:00-8:25:

      Canada 
      Ken LeDez, MD

       

      8:25-8:50:

      United Kingdom
      Pieter Bothma, MD

      The infamous postcode lottery of obtaining funding for HBO depending on where you live, has been criticized widely. It also apply to other specialties including oncology where the most expensive medication was available in some areas and in many areas it was not.  While negotiating a new commissioning policy for HBO as a specialized service, NHS England agreed a block contract to treat the majority of the conditions that we prefer to treat. The policy was due to be completed in 1 to 2 years, but took seven years. This has now been replaced by the new commissioning policy which is a lot more restrictive.

      About Dr. Bothma: Dr. Bothma is a Consultant in Anaesthesia, Critical-care and Hyperbaric medicine. He is Medical director of the London hyperbaric unit operating at 2 sites: in London(Whipps Cross University Hospital) and in Great Yarmouth (James Paget University hospital). He has been involved with the clinical reference group negotiating with NHS England for the last 7 years about a new commissioning policy. He regards this  as the biggest investment of his time for the least benefit to anyone. He is currently chairman of the British Hyperbaric Association.

       

      8:50-9:15:

      United States
      Caroline Fife, MD

       

      9:15-9:40:

      Australia
      Michael Bennett, MD

       

      9:40-10:00:

      Panel discussion

       

       

       

      1:00-1:30:

      HBO2 and Inflammatory Bowel Disease Update
      Jay Buckey, MD

      Buckey

      This talk will cover new developments in the treatment of inflammatory bowel disease with hyperbaric oxygen. Inflammatory bowel disease involves both hypoxia and inflammation, and hyperbaric oxygen can have effects on both of those factors. Also, hyperbaric oxygen can affect the microbiome, which is another potential mechanism for HBO2’s effects in IBD.

      About Dr. Buckey:  Jay C. Buckey, MD is a Professor of Medicine at the Geisel School of Medicine at Dartmouth and the medical director of the Center for Hyperbaric Medicine at Dartmouth-Hitchcock Medical Center. 

      1:30-2:00:

      Thai dive rescue
      Richard Walker, MD

       


      Topics in Undersea and Hyperbaric Medicine

      4:00-4:30:

      Top articles in HBO2
      Fellow (TDB)

       

      4:30-5:00:

      Top articles in Undersea Medicine
      Fellow (TDB)

       

    Read more

  • Continuing Education Credits: Annual Meeting

    In order to receive continuing education for the UHMS ASM you must complete and submit an evaluation.

    Accreditation Statement:  
    The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Designation Statements: 
    The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of TBD AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing CEU is approved by the Florida Board of Registered Nursing Provider #50-10881. ASM Credit hours TBD.
    Licenses Types Approved:

    • Advanced Registered Nurse Practitioner
    • Clinical Nurse Specialist
    • Licensed Practical Nurse
    • Registered Nurse
    • Certified Nursing Assistant
    • Respiratory Care Practitioner Critical Care
    • Respiratory Care Practitioner Non-Critical Care
    • Registered Respiratory Therapist
    • Certified Respiratory Therapist

    NBDHMT: This live activity is approved for TBD Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203.

    Full Disclosure Statement:
     All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.

    Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only.  The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society

     

    MAINTENANCE OF CERTIFICATION (MOC):

    “MOC ABPM: This activity has been approved by the American Board of Preventive Medicine for up to 18 MOC credits. Claiming ABPM MOC credit is appropriate for those who are ABPM diplomates.”

    Read more

  • Social Events

     

    WEDNESDAY, JUNE 26

    WELCOME RECEPTION
    7:00 pm - 9:00 pm

    THURSDAY, JUNE 27

    EXHIBITORS WINE & CHEESE RECEPTION
    6:00 pm - 7:00 pm
    Exhibit Hall 

    SATURDAY, JUNE 29

    ANNUAL AWARDS BANQUET (additional fees for banquet and after party)
      Banquet Reception: 7:00 pm - 7:30 pm
      Dinner: 7:30 pm - 10:00 pm 
      After Party: 10:00pm - 12am  

    Read more

  • Committee Meeting Schedule

    SUBJECT TO CHANGE
    posted 1-28-19

    Please contact lisa@uhms.org to schedule

    Confirmed meetings are highlighted in yellow

    Please note that there will not be any Accreditation Surveyor Training this year in PR. 

    START
    TIME

    END
    TIME

    EVENT

    LOCATION

    TUESDAY, June 25

    4:00 PM

    11:00 PM

    UHMS Board of Directors Meeting (Private Meeting)

     

    WEDNESDAY, June 26

    1:00 PM

    3:00 PM

    CHT/CHRN Study Hall

    Heron

    3:30 PM

    5:30 PM

    CHT/CHRN Exam

    Heron

    4:45 PM

    7:45 PM

    HBO Therapy Committee Meeting

    Canary

    5:30 PM

    7:30 PM

    Associate's Council Meeting

    Pelican

    THURSDAY, June 27

    7:00 AM

    8:00 AM

    Safety Committee Meeting

    Heron

    10:00 AM

    12:00 PM

    Accreditation Council Meeting

    Heron

    10:00 AM

    11:00 AM

    ACEP UHM Section Meeting

    Canary

    11:00 AM

    12:00 PM

    GME Committee Meeting

    Canary

    3:00 PM

    5:00 PM

    Editorial Board Meeting

    Heron

    5:00 PM

    6:00 PM

    Education Committee Meeting

    Pelican

    FRIDAY, June 28

    7:00 AM

    8:00 AM

    Past President’s Breakfast

    Canary

    10:00 AM

    11:00 AM

    ECCHO Working Group Meeting

    Heron

    10:00 AM

    11:00 AM

    Publication Committee Meeting

    Canary

    10:00 AM

    12:00 PM

    ACHM-UHMS Meeting

    Pelican

    11:30 AM

    12:30 AM

    Registry Meeting (Buckey)

    Canary

    2:00 PM

    3:00 PM

    QUARC Committee Meeting

    Heron

    3:00 PM

    4:00 PM

    Research Committee Meeting

    Heron

    5:30 PM

    6:30 PM

    UHMS Business Meeting - Open meeting

    Rio Mar 6-10 & Cord B

    5:30 PM

    7:30 PM

    Specialty Council Meeting (Toups) PRIVATE Meeting

    Pelican

    SATURDAY, June 29

    10:00 AM

    11:00 AM

    Chapter President's Committee Meeting

    Pelican

    10:00 AM

    12:00 PM

    Diving Committee Meeting

    Canary

    11:00 AM

    12:00 PM

    Membership Committee Meeting

    Pelican

    Read more